Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Christopher Ford to Neurotransmitter Agents

This is a "connection" page, showing publications Christopher Ford has written about Neurotransmitter Agents.

 
Connection Strength
 
 
 
0.780
 
  1. Barcomb K, Ford CP. Alterations in neurotransmitter co-release in Parkinson's disease. Exp Neurol. 2023 12; 370:114562.
    View in: PubMed
    Score: 0.216
  2. Ford CP, Dryden WF, Smith PA. Neurotrophic regulation of calcium channels by the peptide neurotransmitter luteinizing hormone releasing hormone. J Neurosci. 2003 Aug 06; 23(18):7169-75.
    View in: PubMed
    Score: 0.213
  3. Ford CP, Stemkowski PL, Light PE, Smith PA. Experiments to test the role of phosphatidylinositol 4,5-bisphosphate in neurotransmitter-induced M-channel closure in bullfrog sympathetic neurons. J Neurosci. 2003 Jun 15; 23(12):4931-41.
    View in: PubMed
    Score: 0.211
  4. Courtney NA, Mamaligas AA, Ford CP. Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. J Neurosci. 2012 Sep 26; 32(39):13520-8.
    View in: PubMed
    Score: 0.100
  5. Silm K, Yang J, Marcott PF, Asensio CS, Eriksen J, Guthrie DA, Newman AH, Ford CP, Edwards RH. Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties. Neuron. 2019 05 22; 102(4):786-800.e5.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)